ClinicalTrials.Veeva

Menu

Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina

C

CHEOL WHAN LEE, MD, PhD.

Status

Terminated

Conditions

Coronary Artery Diseases

Treatments

Other: 18-F Sodium Fluoride Uptake in Positron emission tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT01665248
AMCCV2012-03

Details and patient eligibility

About

The purpose of this study is to evaluate the correlations between active calcification and vulnerable plaque.

Enrollment

20 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age more than 20
  • Acute coronary syndrome or stable angina

Exclusion criteria

  • Contraindications to the use of heparin, aspirin, clopidogrel, stainless metal, contrast media
  • Acute ST segment elevation myocardial infarction within 12hours, heart failure, cardiac shock
  • Any serious medical comorbidity such that the subject's life expectancy is less than 24 months
  • Ejection fraction less than 30
  • Serum creatinine level of 1.5mg/dl and over
  • Vasculitis
  • Unwillingness or inability to cooperate or to give informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

stable angina pectoris or acute coronary syndrome
Other group
Treatment:
Other: 18-F Sodium Fluoride Uptake in Positron emission tomography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems